| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd359506271bdc0de2f51d49099ea1d5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 |
| filingDate |
2000-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8c79381b7045c686adbca73db154c6b |
| publicationDate |
2000-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0066109-A2 |
| titleOfInvention |
Intravenous valproate for acute treatment of migraine headache |
| abstract |
The present invention features a novel therapy for effecting acute treatment of migraine headache. The therapy involves intravenous administration of valproate and is equal to and in some respects superior to previously-known therapies for abortive treatment of prolonged moderate to severe acute migraine headache. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8937096-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8716231-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7141247-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8283478-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8691867-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8492431-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7163689-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8497298-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8853263-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815939-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8809385-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8084490-B2 |
| priorityDate |
1999-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |